Cimetidine 800mg tablets

Страна: Великобритания

Язык: английский

Источник: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активный ингредиент:

Cimetidine

Доступна с:

Dowelhurst Ltd

код АТС:

A02BA01

ИНН (Международная Имя):

Cimetidine

дозировка:

800mg

Фармацевтическая форма:

Oral tablet

Администрация маршрут:

Oral

класс:

No Controlled Drug Status

Тип рецепта:

Valid as a prescribable product

Обзор продуктов:

BNF: 01030100

тонкая брошюра

PACKAGE LEAFLET: INFORMATION FOR THE USER
CIMETIDINE 200 MG, 400 MG & 800 MG TABLETS
(CIMETIDINE)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others.
It may harm them, even if their symptoms are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any
possible side effects not listed in this leaflet. See section 4.
IN THIS LEAFLET:
1. WHAT CIMETIDINE TABLETS ARE AND WHAT THEY ARE USED FOR
2. BEFORE YOU TAKE CIMETIDINE TABLETS
3. HOW TO TAKE CIMETIDINE TABLETS
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE CIMETIDINE TABLETS
6. CONTENTS OF THE PACK AND OTHER INFORMATION
1.
WHAT CIMETIDINE TABLETS ARE AND WHAT THEY ARE USED FOR
The name of your medicine is Cimetidine Tablets. It contains the
active ingredient
called Cimetidine. Cimetidine belongs to a group of medicines called
Histamine
H2 - receptor antagonists and is used as anti-ulcer drug. It works by
reducing the
amount of acid in your stomach.
The tablets are used to treat and relieve the following conditions:
•
Ulcers in the stomach (gastric ulcer) and in upper part of the
intestine
(duodenum ulcer)
•
Recurrent or stomach ulcers (ulcers that keep coming back or which
have
occurred following stomach surgery).
•
Ulcers in the stomach or duodenum which may be caused by non-steroidal
anti-inflammatory drugs (NSAIDs, often used to reduce pain, fever and
inflammation)
•
Acid from the stomach escaping into the food pipe causing pain,
inflammation
and heartburn (oesophageal reflux).
•
Persistent heartburn and stomach pain.
•
Upper abdominal pain particularly after meals
•
Prevent of internal bleeding from ulcers caused by stress in seriously
ill patients.
•
For patients at risk of acid inhalation before general anaesthesia
particularly
pregnant women during labour (Mendelson's syndrome)

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Cimetidine 800mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Cimetidine 800mg
For excipients see 6.1.
3
PHARMACEUTICAL FORM
Film coated tablets.
_Appearance:_
Pale green, oval, film coated tablet, plain on one side and embossed
‘CIM
800’ on the reverse.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Cimetidine tablets are indicated for the following:
1.
In the treatment of duodenal and benign gastric ulceration, recurrent
and stomach ulceration and oesophageal reflux disease.
2.
In the treatment of persistent dyspeptic symptoms with or without
ulceration, particularly meal-related upper abdominal pain.
3.
In
the
prophylaxis
of
gastrointestinal
haemorrhage
from
stress
ulceration in seriously ill patients.
4.
Before general anaethesia in patients thought to be at risk of acid
aspiration
(Mendelson’s)
syndrome,
particularly
obstetric
patients
during labour.
5.
To reduce malabsorption and fluid loss in short bowel syndrome.
6.
To
reduce
degradation
of
enzyme
supplements
in
pancreatic
insufficiency.
7.
In the management of Zollinger-Ellison syndrome.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The total daily dose should not normally exceed 2.4g. Dosage should be
reduced in patients with impaired renal function.
_Adults:_ The usual dosage is 400mg twice daily with breakfast and at
bedtime.
For patients with duodenal or benign gastric ulceration, a single
daily dose of
800mg at bedtime is recommended. Other effective regimens are 200mg
three
times a day with meals and 400mg at bedtime (1.0g/day) and, if
inadequate,
400mg four times a day (1.6g/day) also with meals and at bedtime.
Symptomatic relief is usually rapid. Treatment should be given
initially for at
least four weeks (six weeks in benign gastric ulcer, eight weeks in
ulcer
associated with continued use of non-steroidal anti-inflammatory
agents).
Most ulcers will have healed by that stage, but those which have not
will
usually do so after a further course of tr